Ativan (Lorazepam) in Pregnancy: Miscarriage Risk & Current Evidence
Data on lorazepam (Ativan) and miscarriage risk are inconclusive. Studies show conflicting results:
- Some cohort studies report a modestly increased miscarriage odds, but confounding by indication (anxiety, insomnia, comorbid substance use) is significant.
- Other large registries find no independent association after adjusting for confounders.
- Animal data show fetal loss only at maternally toxic doses.
Clinical Guidance
- Benzodiazepines cross the placenta; neonatal withdrawal, floppy infant syndrome, and possible neurodevelopmental effects are documented with chronic use.
- If possible, discontinue or taper before conception.
- If treatment is essential, use lowest effective dose, consider alternatives (SSRIs, CBT), and involve psychiatry/OB.
- Do not stop abruptly—risk of maternal seizures/withdrawal.
Bottom Line
No definitive causal link to miscarriage established. Decision‑making should balance maternal mental health stability against theoretical fetal risks, individualized with specialist input.
Infertility - Related Articles
- Male Reproductive Anatomy: Penis Structure and Function
- Baby Gender Determination: Mechanism & Timing
- IVF Treatment: A Comprehensive Guide to In Vitro Fertilization
- Pregnancy Risk After Missed Birth Control & Unprotected Sex - Expert Advice
- IVF Children Show No Developmental Differences: Large Oxford Study
- Ovulation Timing: When Are You Most Fertile in Your Cycle?
- Aylmer’s Laboratory Preparations for Birthmark Removal in “The Birthmark”
